Navigation Links
New targeting technology improves outcomes for patients with atrial fibrillation
Date:7/18/2012

In a landmark study of atrial fibrillation, researchers from UCLA, UC San Diego and Indiana University report having found for the first time that these irregular heart rhythms are caused by small electrical sources within the heart, in the form of electrical spinning tops ("rotors") or focal beats.

Importantly, they found a way of detecting these key electrical sources and of shutting them down in minutes using a precisely targeted therapy with long-lasting results.

The team, which included cardiologists, physicists and bioengineers, reports the findings in the July 19 issue of the Journal of the American College of Cardiology as part of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation).

Currently, many atrial fibrillation patients treated with standard therapies will experience a recurrence due to the difficulty of finding the arrhythmia's source. The new research will help cardiologists better target and treat arrhythmias.

The CONFIRM study examined 107 patients with atrial fibrillation who had been referred for a non-surgical catheter ablation procedure. During this procedure, doctors thread a wire with a metal-tipped catheter through the body, from a vein in the groin to the heart, to apply heat to the area of the heart producing the arrhythmia to stop it.

In one group of patients, the team used the new technique to help perform very small, precise burns called focal impulse and rotor modulation, or FIRM that were aimed directly at the fundamental source of the arrhythmia: the tiny electrical disturbances in the heart called focal beats or 'rotors' that look like mini-tornadoes or spinning tops. Rotors can be likened to an "eye of a storm" shown in this study to cause atrial fibrillation. Remarkably, this new procedure shut down or very significantly slowed atrial fibrillation in 86 percent of patients in an average of just 2.5 minutes.

As a comparison, conventional catheter procedures were performed in a second group of patients. Since this approach is less targeted, it involved hours of treatment over larger regions in the heart and often did not shut down the atrial fibrillation.

To track outcomes, patients received an implanted ECG monitor that very accurately assessed their heart rhythms over time. The researchers found that after two years, the FIRM-guided group had an 82.4 percent freedom from atrial fibrillation episodes, compared with only 44.9 percent freedom in the group that received standard therapy.

The new targeted method demonstrated an 86 percent improvement over the conventional method.

"We are very excited by this trial, which for the first time shows that atrial fibrillation is maintained by small electrical hotspots, where brief FIRM guided ablation can shut down the arrhythmia and bring the heart back to a normal rhythm after only minutes of ablation," said lead author Dr. Sanjiv Narayan, a professor of medicine at UC San Diego, visiting professor at the UCLA Cardiac Arrhythmia Center, and director of electrophysiology at the San Diego Veterans Affairs Medical Center.

"The results of this trial, with an 80 percent ablation success rate after a single procedure, are very gratifying," said study author Dr. Kalyanam Shivkumar, director of the UCLA Cardiac Arrhythmia Center and a professor of medicine and radiological sciences at UCLA. "This is the dawn of a new phase of managing this common arrhythmia that is mechanism-based."


'/>"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles Health Sciences
Source:Eurekalert  

Related medicine news :

1. Scientists tailor cell surface targeting system to hit organelle ZIP codes
2. IBN discovers human neural stem cells with tumor targeting ability
3. Mechanical tissue resuscitation technology shows promise
4. New study identifies how information technology is used to solve global health challenges
5. Power generation technology based on piezoelectric nanocomposite materials developed by KAIST
6. Simulation technology allows users to safely practice phacoemulsification cataract surgery
7. The Casey Group's Sales Navigator Wins 2012 Best Mobility App in the New Jersey Technology Council's Mobile Application Competition
8. Swanson Health Products Introduces a New Alkalizing Drink Mix, Swanson® pH Balance Alka-Tone with Alka-Plex™ Technology
9. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
10. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
11. IVR Technology Group Named Platimum VAR by TSYS
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New targeting technology improves outcomes for patients with atrial fibrillation
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ ... Bayfront and Erie Convention Center on June 8-10. The weekend consisted of ... bowl, award and scholarship presentations, and professional networking. , On Friday June ...
(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... By scoring 100% for fiscal ... four-star rating from premier online charity evaluator, Charity Navigator, validating ANRF's work as a ... all charities reviewed by Charity Navigator and earns ANRF a spot on their “ ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that ... the risk of visual loss in these patients. , But how often do ophthalmologists ... smoking cessation to patients at risk of or with early symptoms of AMD? A ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
(Date:5/24/2017)... May 24, 2017  ivWatch LLC today announced ... (OEM) Board to enable seamless integration of ivWatch,s ... systems, infusion pumps and other devices. By integrating ... able to help health care customers deliver a ... related to IV therapy. "The ivWatch ...
Breaking Medicine Technology: